 |
 |
 | CLINICAL NUCLEAR CARDIOLOGY
|  |
 |  |  |
 |
 |
State of the Art and Future Directions
To order this title, and for more information, click here
Third Edition
By
Barry Zaret, MD, Robert W. Berliner Professor of Medicine, Professor of Diagnostic Radiology, Chief, Section of Cardiovascular Medicine, Associate
Chair for Clinical Affairs, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT
George Beller, MD, Ruth C. Heede Professor of Cardiology and Professor of Medicine, University of Virginia School of Medicine; Cardiovascular Division,
Department of Internal Medicine, University of Virginia Health System, Charlottesville, VA
Description
This completely revised 3rd Edition delivers up-to-date coverage of the most recent developments in technology, instrumentation, and radiopharmaceuticals?and
now it's in full color! Internationally recognized experts in the field discuss the full range of nuclear cardiology applications, helping
readers gain a better perspective on the current and future use of radionuclides in imaging diagnosis of the heart.
Audience
Cardiology
Contents
I. Radiopharmaceuticals/Tracer Kinetics
Overview of Kinetics and Modeling
Kinetics on a Cellular Level
Role of Intact Biological Models for Evaluation of Radiotracers
II. Instrumentation
SPECT Processing,
Quantification, and Display
SPECT Artifacts
Attenuation/Scatter/Resolution Correction: Physics Aspects
Attenuation/Scatter
Correction: Clinical Aspects
Dynamic Cardiac SPECT Using Fast Data Acquisition Systems
The New Generation PET/CT Scanners:
Implications for Cardiac Imaging
State of the Art Instrumentation for PET and SPECT Imaging in Small Animals
III.
Ventricular Function
Cardiac Performance
Regional and Global Ventricular Function and Volumes from SPECT Perfusion
Imaging
IV. Perfusion Imaging
Coronary Artery Disease: Exercise Stress
Coronary Artery Disease
Detection: Pharmacologic Stress
Prognosis Applications of Myocardial Perfusion Imaging: Exercise Stress
Prognostic Value
of Pharmacologic Stress Myocardial Perfusion Scintigraphy And Its Use In Risk Stratification
Myocardial Perfusion Imaging Using
Non-Radionuclide Techniques
Cost Effectiveness of Myocardial Perfusion SPECT
V. Disease/Gender Specific Issues
Imaging
in Women
Imaging for Preoperative Risk Stratification
Nuclear Imaging in Patients with a History of Coronary Revascularization
Stress Myocardial Pefusion Imaging in Patients with Diabetes Mellitus
Radionuclide Imaging in Heart Failure and Cardiomyopathies
Imaging in Patients Receiving Cardiotoxic Chemotherapy
Mechanistic and Methodological Considerations for the Imaging of Mental
Stress Ischemia
Measurement of Myocardial Blood Flow and Monitoring Therapy
VI. Acute Coronary Syndromes
Imaging
Patients with Chest Pain in the Emergency Department
Measuring the Efficacy of Therapy in Acute Myocardial Infarction with
Technetium-99m-SESTAMIBI Imaging
Risk Stratification After ST Elevation Acute MI
Risk Stratification in Acute Coronary
Syndromes
VII. Viability
Physiologic and Metabolic Basis of Myocardial Viability Imaging
Assessment
of Myocardial Viability with Thallium-201 and Technetium-Based Agents
Assessment of Myocardial Viability With PET
Comparison
with Non-Nuclear Techniques
VIII. Tracer Specific Imaging Techniques
Fatty Acid Imaging
Cardiac
Neurotransmitter Imaging: SPECT
Cardiac Neurotransmitter Imaging: PET
Receptor Imaging
IX. New Molecular
Approaches
New Molecular Approaches For Imaging of Angiogenesis and Hypoxia
Noninvasive Detection of Cell Death
in Myocardial Disorders
Radionuclide Approach to Imaging of Inflammation in Atheroma for the Detection of Lesions Vulnerable to
Rupture
Molecular Imaging of Gene Products
Imaging Myocardial Inflammation
Section X: Mini-Atlas of Case
Presentations
| Bibliographic details |
Hardbound, 768 pages, publication date: OCT-2004
ISBN-13: 978-0-323-02494-5
ISBN-10: 0-323-02494-7
Imprint: MOSBY
|
042/423
Last update: 10 Sep 2009
|
 |
|  |
 |  |  |
 |
|
|  |